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Should I stay or should I go? Pulmonary embolism and air travel 
Sir,
The global rise in air travel, with over 3.97 
billion people traveling by air each year, and the 
aging population, increase the number of those 
with an illness who wish to travel [1]. Even more, 
in countries like Greece with hundreds of islands, 
health professionals are frequently asked to ass-
ess a patient’s fitness to fly. Doctors can receive 
advice and guidance mainly from two sources: 
the IATA passenger medical clearance guidelines 
and the Aerospace Medical Association in which 
the British Thoracic Society’s recommendations 
for air travel are suggested [2, 3].
Many respiratory conditions can affect a pas-
senger’s fitness to fly with pulmonary embolism 
being the most debatable [3]. A major question that 
respiratory physicians frequently have to answer, 
mostly with visitors from overseas who need to be 
repatriated following diagnosis of pulmonary em-
bolism, is about the right time to “fly with a clot”. 
The British Thoracic Society guidelines recommend 
against airline travel during the first four weeks fol-
lowing pulmonary embolism [3]. On the other hand, 
in the IATA medical guidelines published in 2018, 
it is suggested that patients can fly 5 days after an 
acute pulmonary embolism episode if they receive 
anticoagulation and their PaO2 is normal on room 
air [2]. Although there is little scientific evidence to 
support the above mentioned recommendations, the 
huge difference in the suggested period can really 
confuse healthcare professionals. Moreover, asking 
patients-tourists to remain in a travel destination one 
month more than scheduled, launches their cost of 
stay and many times they are proven unable to follow 
this recommendation. 
In our opinion, one size does not fit all. The 
4-week period seems too long for a patient with pul-
monary embolism severity index I or II, no evidence 
of right ventricular dysfunction on an imaging test, 
negative laboratory biomarkers on presentation 
(low-risk patient) and a normal PaO2 on room air 
[4]. On the other hand, the 4-week period and even 
more, the 5-day period may be too short for a patient 
with pulmonary embolism severity index III–V, 
evidence of right ventricular dysfunction on an 
imaging test and positive laboratory biomarkers on 
presentation (intermediate high-risk patient), who 
has a significantly higher mortality rate during the 
first thirty days even without traveling [4]. 
Thus, we believe that the risk of flying after 
being diagnosed with pulmonary embolism is 
not the same for all patients and in every case we 
should take into consideration the risk stratifica-
tion on presentation and the PaO2 level. Further 
carefully designed studies taking into account 
risk stratification will give the answer to the to-
ugh question “should I stay or should I go” after 
pulmonary embolism.
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